Insider Selling: Nature's Sunshine Products, Inc. (NASDAQ:NATR) CAO Sells 5,000 Shares of Stock

Key Points

• CAO Jonathan David Lanoy of Nature's Sunshine Products sold 5,000 shares at an average price of $16.51, resulting in a transaction worth $82,550 and a 9.08% decrease in his ownership.
• The company's last quarterly earnings showed an EPS of $0.35, surpassing estimates of $0.16, with revenues of $114.75 million exceeding expectations.
• Analysts have positive outlooks for Nature's Sunshine Products, with a buy rating and price targets set between $19.00 and $22.00 based on recent reports.

Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) CAO Jonathan David Lanoy sold 5,000 shares of the stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $16.51, for a total transaction of $82,550.00. Following the sale, the chief accounting officer directly owned 50,051 shares of the company's stock, valued at approximately $826,342.01. The trade was a 9.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Nature's Sunshine Products Price Performance

NATR traded down $0.04 during trading on Friday, reaching $16.54. 35,925 shares of the company's stock were exchanged, compared to its average volume of 61,688. Nature's Sunshine Products, Inc. has a 1 year low of $11.01 and a 1 year high of $18.06. The stock has a market capitalization of $291.84 million, a P/E ratio of 22.36 and a beta of 1.14. The company's fifty day simple moving average is $15.10 and its 200-day simple moving average is $14.03.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported $0.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.19. The firm had revenue of $114.75 million for the quarter, compared to analysts' expectations of $113.10 million. Nature's Sunshine Products had a net margin of 3.06% and a return on equity of 10.19%.

Analyst Ratings Changes

Several analysts have commented on NATR shares. DA Davidson reissued a "buy" rating and set a $19.00 price target on shares of Nature's Sunshine Products in a research report on Tuesday, June 3rd. Canaccord Genuity Group increased their price objective on shares of Nature's Sunshine Products from $21.00 to $22.00 and gave the company a "buy" rating in a research report on Friday, August 1st.

Hedge Funds Weigh In On Nature's Sunshine Products

Institutional investors and hedge funds have recently bought and sold shares of the business. GAMMA Investing LLC raised its holdings in Nature's Sunshine Products by 2,090.2% in the 1st quarter. GAMMA Investing LLC now owns 2,234 shares of the company's stock valued at $28,000 after buying an additional 2,132 shares during the period. MTM Investment Management LLC purchased a new stake in Nature's Sunshine Products in the 2nd quarter valued at about $30,000. Raymond James Financial Inc. purchased a new stake in Nature's Sunshine Products in the 2nd quarter valued at about $37,000. Russell Investments Group Ltd. purchased a new stake in Nature's Sunshine Products in the 4th quarter valued at about $41,000. Finally, Deutsche Bank AG purchased a new stake in Nature's Sunshine Products in the 4th quarter valued at about $103,000. 79.40% of the stock is currently owned by institutional investors and hedge funds.

About Nature's Sunshine Products

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.